BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

CANCvsGNOMETF Comparison

ETF 1

CANC

Tema Oncology ETF

This fund is part of

Tomorrow's Treatments

+0.67%

Full CANC fund page

VS

ETF 2

GNOM

Global X Genomics & Biotechnology ETF

This fund is part of

BioTech & Genomics

-0.39%

Full GNOM fund page

Tema Oncology ETF (CANC) belongs to the Tomorrow's Treatments segment. Global X Genomics & Biotechnology ETF (GNOM) is part of the BioTech & Genomics segment. Both ETFs have the same top 3 sector exposures: and Health Care. CANC is more expensive with a Total Expense Ratio (TER) of 0.99%, versus 0.5% for GNOM. CANC is up 8.22% year-to-date (YTD) with +$52M in YTD flows. GNOM performs worse with 7.73% YTD performance, and +$4M in YTD flows. Run a side-by-side ETF comparison of CANC and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

CANC vs GNOM performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 06/12/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	CANC GNOM	-0.48%+4.86%	+3.95%+12.44%	+8.22%+7.73%	+45.49%+47.34%	n/a-2.60%	n/a-46.66%
Flows	CANC GNOM	+$5M+$4M	+$11M+$6M	+$52M+$4M	+$69M-$4M	--$104M	-+$8M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	CANC GNOM	+24.37%+31.23%	+22.62%+26.53%	n/a+28.94%	n/a+33.27%
Max drawdown	CANC GNOM	-9.20%-7.88%	-9.20%-18.16%	n/a-46.21%	n/a-72.17%
Max drawdown duration	CANC GNOM	54d36d	54d141d	n/a1095d	n/a1807d

Trading data

Create an account to view trading data

Join for free

	CANC	GNOM
Last sale 6/12/2026 at 1:30 PM	$37.48	$48.95
Previous close 06/11/2026	$37.26	$49.13
Consolidated volume 06/11/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of May 29, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

CANC

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	CANC	GNOM
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 6/12/2026 at 1:30 PM

Live

Closed

	CANC	GNOM
Last price	$37.48	$48.95
1D performance	+0.60%	-0.36%
AuM	$178.42 M	$59.59 M
E/R	0.99%	0.5%

Characteristics

	CANC	GNOM
Management strategy	Active	Passive
Provider	Tema	Global X
Benchmark	-	Solactive Genomics Index
N° of holdings	42	45
Asset class	-	Equities
Trailing 12m distribution yield	Join	Join
Inception date	August 15, 2023	April 5, 2019
ESG	No	No

More CANC data on Trackinsight

More GNOM data on Trackinsight

Exposure

Countries

CANC

USA

87.11%

Other

12.89%

GNOM

USA

88%

Other

12%

Sectors

CANC

Health Care

76.64%

Other

23.36%

GNOM

Health Care

88.52%

Other

11.48%

Diversification

CANC

Total weight of top 15 holdings out of 15

54.47%

GNOM

Total weight of top 15 holdings out of 15

66.44%

Top 15 holdings

Data as of April 30, 2026

CANC

REVOLUTION MEDICINES INC

6.51%

IMMUNOME

4.24%

US7711951043

4.15%

COGENT BIOSCIENCES

4.07%

NOVARTIS

4.00%

LILLY

3.81%

ASTRAZENECA

3.62%

BRISTOL-MYERS SQUIBB

3.36%

MERCK & CO INC

3.34%

CELCUITY INC

3.31%

NUVALENT

3.20%

BRIDGEBIO PHARMA

2.84%

US3723032062

2.82%

LEGEND BIOTECH

2.63%

US98887Q1040

2.57%

GNOM

MODERNA INC

7.59%

ARROWHEAD PHARMACEUTICALS INC

7.18%

US74006W2070

6.77%

ILLUMINA

5.19%

GUARDANT HEALTH INC

4.73%

BIOMARIN PHARMACEUTICAL

4.29%

VERTEX PHARMACEUTICALS

4.16%

NATERA

4.14%

BIONTECH SE ADR

4.03%

BIO-TECHNE CORP

3.44%

CRISPR THERAPEUTICS

3.32%

TWIST BIOSCIENCE CORP

3.14%

LEGEND BIOTECH

2.91%

NL0015002SN0

2.77%

BRISTOL-MYERS SQUIBB

2.77%

Frequently asked questions about CANC and GNOM

How have the CANC and GNOM ETFs performed in 2026?

As of June 12, 2026, CANC is up 8.22% year-to-date (YTD), while GNOM has returned 7.73%. That puts CANC better performer ahead so far this year.

Which ETF is attracting more investor money: CANC or GNOM?

Year-to-date, the CANC ETF saw +$52M in flows, compared to +$4M for GNOM.

Which ETF is more volatile: CANC or GNOM?

Over the past year, CANC had a volatility of 22.62%, while GNOM experienced 26.53%.

Which ETF is bigger: CANC or GNOM?

As of June 12, 2026, CANC holds $178.42 M in assets under management (AUM), while GNOM manages $59.59 M.

What sectors do the CANC and GNOM ETFs invest in?

CANC leans toward sectors like Health Care. Meanwhile, GNOM focuses on Health Care.

What are the top holdings of the CANC ETF and GNOM ETF?

CANC top holdings include REVOLUTION MEDICINES INC, IMMUNOME and US7711951043. GNOM holds in its top three: MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and US74006W2070.

CANCvsGNOMETF Comparison

Tema Oncology ETF

Global X Genomics & Biotechnology ETF

CANC vs GNOM performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the CANC and GNOM ETFs performed in 2026?

As of June 12, 2026, CANC is up 8.22% year-to-date (YTD), while GNOM has returned 7.73%. That puts CANC better performer ahead so far this year.

Which ETF is attracting more investor money: CANC or GNOM?

Year-to-date, the CANC ETF saw +$52M in flows, compared to +$4M for GNOM.

Which ETF is more volatile: CANC or GNOM?

Over the past year, CANC had a volatility of 22.62%, while GNOM experienced 26.53%.

Which ETF is bigger: CANC or GNOM?

As of June 12, 2026, CANC holds $178.42 M in assets under management (AUM), while GNOM manages $59.59 M.

What sectors do the CANC and GNOM ETFs invest in?

CANC leans toward sectors like Health Care. Meanwhile, GNOM focuses on Health Care.

What are the top holdings of the CANC ETF and GNOM ETF?

CANC top holdings include REVOLUTION MEDICINES INC, IMMUNOME and US7711951043. GNOM holds in its top three: MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and US74006W2070.

Which ETF is more diversified: CANC or GNOM?

CANC holds 53 securities with 54.47% of its assets in the top 15. GNOM has 49 securities and a top 15 weight of 66.44%.

Build and Analyze Your ETF Portfolio Like a Pro